The adoption of biosimilars is increasing, with a predicted global market CAGR of 18%, though uptake varies by market and is ...
Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, hopes to use the conference to explore how ...
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...
Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global ...
In addition, many adults (67%) also think policymakers should keep access- and coverage-related factors in mind, namely ...
As the FDA ends its phased exemption period for most trading partners, Two Labs’ Michael Rowe warns that DSCSA compliance is ...
Various agreements with the Trump administration could have long-term ramifications for Medicaid access and global pricing strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback